- Filed
- May 20, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 13, 2025 | 32.2M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $10.07M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $37.65M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $28.42M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $9.69M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.55M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $12.69M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $5.5M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $49.29M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $29.25M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $49.29M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $29.25M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 758.97K sh |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$131.26K |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | −$5.65M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | −$5.52M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.20 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.20 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $143.86K |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $7.81K |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$151.68K |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$151.68K |